References |
1 |
Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose
|
2 |
DrugBank(Pharmacology-Metabolism):Isocarboxazid
|
3 |
Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates
|
4 |
Midostaurin, a novel protein kinase inhibitor for the treatment of acute myelogenous leukemia: insights from human absorption, metabolism, and excretion studies of a BDDCS II drug. Drug Metab Dispos. 2017 May;45(5):540-555.
|
5 |
DrugBank(Pharmacology-Metabolism):Fluoxetine hydrochloride
|
6 |
DrugBank(Pharmacology-Metabolism)Amphetamine
|
7 |
Catabolism of citrus flavanones by the probiotics Bifidobacterium longum and Lactobacillus rhamnosus. Eur J Nutr. 2018 Feb;57(1):231-242.
|
8 |
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
|
9 |
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. Neuropharmacology. 2014 Dec;87:41-50.
|
10 |
In vitro catabolism of 3',4'-dihydroxycinnamic acid by human colonic microbiota
|
11 |
Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate
|